In Focus: MMI Speaker Kathleen Scott


Kathleen Scott PhD, is a Clinical Program Leader at Cancer Trials Ireland (formerly ICORG) and is responsible for the oversight of a number of cancer and haematology trials programs.

She has gained more than 20 years cancer clinical research experience in academic, clinical, and pharmaceutical settings throughout the UK, Australia, and Ireland. Since arriving in Ireland 5 years ago, she was awarded a Cochrane Fellowship based at Trinity College Dublin by the Health Research Board. In her role at Cancer Trial Ireland, she co-leads a team of approximately 30 clinical research staff working across a diverse range of clinical trials and has program responsibility for haematology trials including multiple myeloma.

She has worked proactively with lead haematologists in Ireland, international collaborators and pharmaceutical partners to design and develop new trials and bring new myeloma treatments to patients in Ireland. Kathleen published a Cochrane Review in 2016 titled ‘Bortezomib for the treatment of multiple myeloma’.

For more information on MMI 2016 please click here

Need more information from us?

Stay Updated

Speak confidentially with our support services team for information and support.

Call +353 86 022 6992 or email

Together we can help patients & carers of multiple myeloma.

2020 © All rights reserved of Multiple Myeloma Ireland | Multiple Myeloma Patient & Carer Support
Multiple Myeloma Ireland c/o Cancer Centre, Haem/Onc Day Unit, Limerick University Hospital.
Loading please wait